HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.

AbstractBACKGROUND:
Lymphovascular invasion (LVI) is a prerequisite step in breast cancer (BC) metastasis. We have previously identified wild-type isocitrate dehydrogenase 2 (IDH2) as a key putative driver of LVI. Thus, we explored the prognostic significance of IDH2 at transcriptome and protein expression levels in pre-invasive and invasive disease.
METHODS:
Utlising tissue microarrays from a large well annotated BC cohort including ductal carcinoma in situ and invasive breast cancer (IBC), IDH2 was assessed at the transcriptomic and proteomic level. The associations between clinicopathological factors including LVI status, prognosis and the expression of IDH2 were evaluated.
RESULTS:
In pure DCIS and IBC, high IDH2 protein expression was associated with features of aggressiveness including high nuclear grade, larger size, comedo necrosis and hormonal receptor negativity and LVI, higher grade, larger tumour size, high NPI, HER2 positivity, and hormonal receptor negativity, respectively. High expression of IDH2 either in mRNA or in protein levels was associated with poor patient's outcome in both DCIS and IBC. Multivariate analysis revealed that IDH2 protein expression was an independent risk factor for shorter BC specific-survival.
CONCLUSION:
Further functional studies to decipher the role of IDH2 and its mechanism of action as a driver of BC progression and LVI are warranted.
AuthorsAbrar I Aljohani, Michael S Toss, Sasagu Kurozumi, Chitra Joseph, Mohammed A Aleskandarany, Islam M Miligy, Rokaya El Ansari, Nigel P Mongan, Ian O Ellis, Andrew R Green, Emad A Rakha
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 179 Issue 1 Pg. 79-90 (Jan 2020) ISSN: 1573-7217 [Electronic] Netherlands
PMID31599393 (Publication Type: Journal Article)
Chemical References
  • IDH2 protein, human
  • Isocitrate Dehydrogenase
Topics
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Carcinoma, Intraductal, Noninfiltrating (genetics, metabolism, pathology)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Isocitrate Dehydrogenase (genetics, metabolism)
  • Multivariate Analysis
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Prognosis
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: